To Evaluate the Efficacy, Safety and Population Pharmacokinetics of GST-HG141 in Patients With Chronic Hepatitis B (CHB) Who Have an Inadequate Response to Antiviral Drug Treatment

NCT07090759 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

526

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis b

Interventions

DRUG: GST-HG141
DRUG: GST-HG141 Placebo

Sponsor

Fujian Akeylink Biotechnology Co., Ltd.